Catherine Leyshon[Author] - Search Results

Year	Number of Results
2017	1
2018	2
2019	1
2021	2
2022	1
2023	2
2024	0

1

Improving health and wellbeing through social prescribing.

Mittal R, Rowse E, Leyshon M, Leyshon C. Mittal R, et al. Among authors: leyshon c. Br J Hosp Med (Lond). 2023 Jul 2;84(7):1-4. doi: 10.12968/hmed.2023.0121. Epub 2023 Jul 4. Br J Hosp Med (Lond). 2023. PMID: 37490444 Free article.

2

Toward optimization of cyclosporine concentration target to prevent acute graft-versus-host disease following myeloablative allogeneic stem cell transplant.

Kwan ACF, Blosser N, Ghosh S, Leyshon C, Dersch-Mills D, Puckrin R, Duggan P, Zepeda V, Savoie L, Stewart D, Storek J, Jamani K. Kwan ACF, et al. Among authors: leyshon c. Clin Transplant. 2022 Aug;36(8):e14732. doi: 10.1111/ctr.14732. Epub 2022 Jun 2. Clin Transplant. 2022. PMID: 35606904

3

Corticosteroids as graft-versus-host disease prophylaxis for allogeneic hematopoietic cell transplant recipients with calcineurin inhibitor intolerance.

Puckrin R, Kwan ACF, Blosser N, Leyshon C, Duggan P, Daly A, Zepeda V, Stewart D, Chaudhry A, Storek J, Jamani K. Puckrin R, et al. Among authors: leyshon c. Cytotherapy. 2023 Oct;25(10):1101-1106. doi: 10.1016/j.jcyt.2023.05.010. Epub 2023 Jun 10. Cytotherapy. 2023. PMID: 37306643

4

Fostering Engagement With Health and Housing Innovation: Development of Participant Personas in a Social Housing Cohort.

Williams AJ, Menneer T, Sidana M, Walker T, Maguire K, Mueller M, Paterson C, Leyshon M, Leyshon C, Seymour E, Howard Z, Bland E, Morrissey K, Taylor TJ. Williams AJ, et al. Among authors: leyshon c. JMIR Public Health Surveill. 2021 Feb 16;7(2):e25037. doi: 10.2196/25037. JMIR Public Health Surveill. 2021. PMID: 33591284 Free PMC article.

5

Clinical outcome of chronic myeloid leukemia patients who switch from first-line therapy with a second generation tyrosine kinase inhibitor to an alternative TKI.

Ma CE, Ghosh S, Leyshon C, Blosser N, Dersch-Mills D, Jupp J, Savoie L, Liew E, Jamani K. Ma CE, et al. Among authors: leyshon c. Leuk Res. 2021 Dec;111:106674. doi: 10.1016/j.leukres.2021.106674. Epub 2021 Jul 24. Leuk Res. 2021. PMID: 34333277

6

Davies T, Cowley A, Bennie J, Leyshon C, Inger R, Carter H, Robinson B, Duffy J, Casalegno S, Lambert G, Gaston K. Davies T, et al. Among authors: leyshon c. PLoS One. 2018 Sep 26;13(9):e0203694. doi: 10.1371/journal.pone.0203694. eCollection 2018. PLoS One. 2018. PMID: 30256838 Free PMC article.

7

Incidence of late onset neutropenia associated with rituximab use in B cell lymphoma patients undergoing autologous stem cell transplantation.

Ha VH, Ghosh S, Leyshon C, Ryan N, Chambers CR, Stewart DA. Ha VH, et al. Among authors: leyshon c. J Oncol Pharm Pract. 2018 Jul;24(5):323-331. doi: 10.1177/1078155217702214. Epub 2017 Mar 30. J Oncol Pharm Pract. 2018. PMID: 28358279

8

Davies T, Cowley A, Bennie J, Leyshon C, Inger R, Carter H, Robinson B, Duffy JP, Casalegno S, Lambert G, Gaston K. Davies T, et al. Among authors: leyshon c. PLoS One. 2019 Feb 6;14(2):e0212101. doi: 10.1371/journal.pone.0212101. eCollection 2019. PLoS One. 2019. PMID: 30726304 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

8 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year